Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eilam

Showing results (451-460 of 475) with videos related to

Pageof 48
Sort By:
EMBO Molecular Medicine|December 8, 2017
An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitorsMaicol Mancini, Hilah Gal, Nadège Gaborit, et al.
Elife|October 5, 2017
Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcomeShiran Ferber, Galia Tiram, Ana Sousa-Herves, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2021
<i>TP53</i> missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironmentMartino Maddalena, Giuseppe Mallel, Nishanth Belugali Nataraj, et al.
Nature Communications|March 27, 2021
P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progressionEilam Yeini, Paula Ofek, Sabina Pozzi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 16, 2024
Potent antitumor activity of anti-HER2 antibody-topoisomerase I inhibitor conjugate based on self-immolative dendritic dimeric-linkerYulia Liubomirski, Galia Tiram, Anna Scomparin, et al.
JCI Insight|August 18, 2022
MCP-1/CCR2 axis inhibition sensitizes the brain microenvironment against melanoma brain metastasis progressionSabina Pozzi, Anna Scomparin, Dikla Ben-Shushan, et al.
The EMBO Journal|September 3, 2015
Dysregulated miRNA biogenesis downstream of cellular stress and ALS-causing mutations: a new mechanism for ALSAnna Emde, Chen Eitan, Lee-Loung Liou, et al.
Theranostics|July 21, 2018
Image-guided surgery using near-infrared Turn-ON fluorescent nanoprobes for precise detection of tumor marginsRachel Blau, Yana Epshtein, Evgeni Pisarevsky, et al.
Science Advances|December 13, 2024
Two-in-one nanoparticle platform induces a strong therapeutic effect of targeted therapies in P-selectin-expressing cancersShani Koshrovski-Michael, Daniel Rodriguez Ajamil, Pradip Dey, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 2, 2018
Reverting the molecular fingerprint of tumor dormancy as a therapeutic strategy for glioblastomaGalia Tiram, Shiran Ferber, Paula Ofek, et al.
Pageof 48

Showing results (451-460 of 475) with videos related to

Sort By:
Pageof 48
EMBO Molecular Medicine|December 8, 2017
An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitorsMaicol Mancini, Hilah Gal, Nadège Gaborit, et al.
Elife|October 5, 2017
Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcomeShiran Ferber, Galia Tiram, Ana Sousa-Herves, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2021
<i>TP53</i> missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironmentMartino Maddalena, Giuseppe Mallel, Nishanth Belugali Nataraj, et al.
Nature Communications|March 27, 2021
P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progressionEilam Yeini, Paula Ofek, Sabina Pozzi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 16, 2024
Potent antitumor activity of anti-HER2 antibody-topoisomerase I inhibitor conjugate based on self-immolative dendritic dimeric-linkerYulia Liubomirski, Galia Tiram, Anna Scomparin, et al.
JCI Insight|August 18, 2022
MCP-1/CCR2 axis inhibition sensitizes the brain microenvironment against melanoma brain metastasis progressionSabina Pozzi, Anna Scomparin, Dikla Ben-Shushan, et al.
The EMBO Journal|September 3, 2015
Dysregulated miRNA biogenesis downstream of cellular stress and ALS-causing mutations: a new mechanism for ALSAnna Emde, Chen Eitan, Lee-Loung Liou, et al.
Theranostics|July 21, 2018
Image-guided surgery using near-infrared Turn-ON fluorescent nanoprobes for precise detection of tumor marginsRachel Blau, Yana Epshtein, Evgeni Pisarevsky, et al.
Science Advances|December 13, 2024
Two-in-one nanoparticle platform induces a strong therapeutic effect of targeted therapies in P-selectin-expressing cancersShani Koshrovski-Michael, Daniel Rodriguez Ajamil, Pradip Dey, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 2, 2018
Reverting the molecular fingerprint of tumor dormancy as a therapeutic strategy for glioblastomaGalia Tiram, Shiran Ferber, Paula Ofek, et al.
Pageof 48